Overview
Guangyao Kong practices in Xi'an, China. Kong is rated as an Advanced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Their top areas of expertise are Hypersplenism, Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasms (MPN), Post-Splenectomy Syndrome, and Splenectomy.
Their clinical research consists of co-authoring 67 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- SplenectomyKong isDistinguished. Learn about Splenectomy.
- Advanced
- Chronic Myelomonocytic Leukemia (CMML)
- HypersplenismKong isAdvanced. Learn about Hypersplenism.
- Myeloproliferative Neoplasms (MPN)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Adult T-Cell LeukemiaKong isExperienced. Learn about Adult T-Cell Leukemia.
- Budd-Chiari SyndromeKong isExperienced. Learn about Budd-Chiari Syndrome.
- CirrhosisKong isExperienced. Learn about Cirrhosis.
- HepatitisKong isExperienced. Learn about Hepatitis.